SITC Archive Library

2015 Advances in Cancer Immunotherapy™ - Washington, DC 

02-03-2017 16:24

2015 Advances in Cancer Immunotherapy™ - Washington, DC
August 7, 2015
Georgetown University Hotel and Conference Center Washington, DC

Program Organizers
Michael B. Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center
Geoffrey T. Gibney, MD – Georgetown-Lombardi Comprehensive Cancer Center
Louis M. Weiner, MD – Georgetown University Medical Center

Program Summary
From the Society for Immunotherapy of Cancer (SITC), these enduring materials from the 2015 Advances in Cancer Immunotherapy™ - Washington, DC provides an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field.

Presented by leading authorities in tumor immunology and cancer immunotherapy, this program facilitated an understanding of:

  1. The underlying principles of tumor immunology and immunotherapy
  2. The clinical indications for cancer immunotherapy and appropriate selection of patients
  3. Patient management
  4. The therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes. 
Intended Audience
The target audience for this program included clinical oncologists, registered nurses, nurse practitioners, others involved in patient care, early career individuals, allied health professionals and patient advocates who wish to learn principles of tumor immunology and immunotherapy, as well as improve their ability to select patients for immunotherapy and provide state-of-the-art clinical management for their patients. 

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#RegisteredNurse #Cytokines #2015 #LungCancers #GenitourinaryCancers #Video #ImmuneCheckpointInhibitors #Oncologist #SITC #PresentationSlides #BrainCancers #AdvancesinCancerImmunotherapy(ACI) #Clinician #Ipilimumab #Nivolumab 
#CombinationTherapy #AdoptiveCellTherapy #Non-SmallCellLungCancer #Melanoma #HematologicMalignancies
#AdverseEvents #Toxicities #RenalCellCarcinoma #ProstateCancer #BladderCancer #ClinicalTrials #Leukemia
#Lymphoma #Small-CellLungCancer #TherapeuticAntibodies #Vaccines #AlliedHealth #Pharmacist #PrimaryCarePhysician

Statistics
0 Favorited
34 Views
9 Files
0 Shares
273 Downloads
Attachment(s)
pdf file
Immunology 101 for the Non-Immunologist Presentation Slides   1.88 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- Washington, DC; Session: Principles of Tumor Immunology; Presentation: Immunology 101 for the Non-Immunologist; Presenters: Louis M. Weiner, MD – Georgetown University Medical Center; Date: August 7, 2015
pdf file
Interferons, Interleukins and Beyond Presentation Slides   2.51 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- Washington, DC; Session: Major Approaches to Tumor Immunotherapy – What the Clinician Needs to Know; Presentation: Cytokines: Interferons, Interleukins and Beyond; Presenters: Michael B. Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center; Date: August 7, 2015
pdf file
Approved Agents, Drugs in Development and Combination St...   3.05 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- Washington, DC; Session: Major Approaches to Tumor Immunotherapy – What the Clinician Needs to Know; Presentation: Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies; Presenters: Mario Sznol, MD – Yale University School of Medicine; Date: August 7, 2015
pdf file
Current Status of Chimeric and Adoptive T Cell Therapy Pr...   5.19 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- Washington, DC; Session: Major Approaches to Tumor Immunotherapy – What the Clinician Needs to Know; Presentation: Current Status of Chimeric and Adoptive T Cell Therapy; Presenters: James C. Yang, MD – National Cancer Institute Surgery Branch; Date: August 7, 2015
pdf file
Is There a Role for Radiation Therapy and Immunotherapy? ...   943 KB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- Washington, DC; Session: Major Approaches to Tumor Immunotherapy – What the Clinician Needs to Know; Presentation: Is There a Role for Radiation Therapy and Immunotherapy?; Presenters: Michael Postow, MD – Memorial Sloan-Kettering Cancer Center; Date: August 7, 2015
pdf file
Immunotherapy for the Treatment of Melanoma Presentation ...   1.66 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- Washington, DC; Session: The Role of Tumor Immunotherapy for Cancer – Clinical Indications and Patient Management; Presentation: Immunotherapy for the Treatment of Melanoma; Presenters: Geoffrey T. Gibney, MD – Georgetown-Lombardi Comprehensive Cancer Center; Date: August 7, 2015
pdf file
Immunotherapy for the Treatment of GU Malignancies Presen...   2.00 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- Washington, DC; Session: The Role of Tumor Immunotherapy for Cancer – Clinical Indications and Patient Management; Presentation: Immunotherapy for the Treatment of GU Malignancies; Presenters: Michael B. Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center; Date: August 7, 2015
pdf file
Immunotherapy for the Treatment of Non-Small Cell Lung Ca...   4.66 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- Washington, DC; Session: The Role of Tumor Immunotherapy for Cancer – Clinical Indications and Patient Management; Presentation: Immunotherapy for the Treatment of Non-Small Cell Lung Carcinoma; Presenters: Julie R. Brahmer, MD – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Date: August 7, 2015
pdf file
Immunotherapy for the Treatment of Brain Metastases Prese...   2.47 MB   1 version
Uploaded - 02-03-2017
Meeting: 2015 Advances in Cancer Immunotherapy™- Washington, DC; Session: The Role of Tumor Immunotherapy for Cancer – Clinical Indications and Patient Management; Presentation: Immunotherapy for the Treatment of Brain Metastases; Presenters: Geoffrey T. Gibney, MD – Georgetown-Lombardi Comprehensive Cancer Center; Date: August 7, 2015